Vivos Therapeutics, Inc.
Ticker: 1716166
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 5.15+0.2% | 5.14-24.2% | 6.78+77.5% | 3.82+26.5% | 3.02-21.8% | 3.86-4.7% | 4.05+18.4% | 3.42 |
| Total Income | 5.15+0.2% | 5.14-24.2% | 6.78+77.5% | 3.82+26.5% | 3.02-21.8% | 3.86-4.7% | 4.05+18.4% | 3.42 |
| EXPENSES | ||||||||
| Expenditure | 9.98-15.1% | 11.76+2.1% | 11.52+32.6% | 8.69+25.4% | 6.93+6.5% | 6.51+8.7% | 5.99-16.8% | 7.20 |
| PROFIT | ||||||||
| PBT | -5.52+28.8% | -7.75-43.5% | -5.40-7.8% | -5.01-29.8% | -3.86-47.3% | -2.62-35.8% | -1.93+48.7% | -3.76 |
| Net Profit | -5.48+28.6% | -7.68-42.2% | -5.40-7.8% | -5.01-29.8% | -3.86-47.3% | -2.62-35.8% | -1.93+48.7% | -3.76 |
| KEY METRICS | ||||||||
| OPM % | -93.64%+6.36pp | -100.00%-30.21pp | -69.79%+30.21pp | -100.00% | -100.00%-31.48pp | -68.52%-20.77pp | -47.76%+52.24pp | -100.00% |
| NPM % | -100.00% | -100.00%-20.39pp | -79.61%+20.39pp | -100.00% | -100.00%-32.23pp | -67.77%-20.17pp | -47.61%+52.39pp | -100.00% |
| EPS | -0.31+40.4% | -0.52-6.1% | -0.49+10.9% | -0.55-22.2% | -0.45-12.5% | -0.40+33.3% | -0.60+63.2% | -1.63 |
Corporate Events
Board MeetingVVOS
202631Jul
Board Meeting
CFO Transition — Bradford Amman resigned as CFO, and Roman F…
SEC Filing ↗